Alector (ALEC) Reports Q4 Loss, Tops Revenue Estimates

分组1 - Alector reported a quarterly loss of $0.02 per share, significantly better than the Zacks Consensus Estimate of a loss of $0.64, representing an earnings surprise of 96.88% [1] - The company posted revenues of $54.24 million for the quarter ended December 2024, exceeding the Zacks Consensus Estimate by 220.64%, compared to $15.19 million in the same quarter last year [2] - Alector has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates two times during the same period [2] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.45 on revenues of $5 million, while for the current fiscal year, it is -$1.97 on revenues of $43.8 million [7] - The Medical - Biomedical and Genetics industry, to which Alector belongs, is currently ranked in the top 24% of over 250 Zacks industries, indicating a favorable outlook for the sector [8] - Alector shares have underperformed the market, losing about 6.4% since the beginning of the year, while the S&P 500 has gained 1.3% [3]